These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 1754222)

  • 1. Treatment options in spasmodic dysphonia.
    Miller RH; Woodson GE
    Otolaryngol Clin North Am; 1991 Oct; 24(5):1227-37. PubMed ID: 1754222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Spasmodic dysphonia. Investigation and therapeutic methods].
    Marion MH; Klap P; Perrin A; Elbaz E
    Rev Neurol (Paris); 1992; 148(3):180-3. PubMed ID: 1604131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spasmodic dysphonia and laryngeal botulinum toxin injection.
    Smith ME
    West J Med; 1993 Jul; 159(1):74. PubMed ID: 8351914
    [No Abstract]   [Full Text] [Related]  

  • 4. [Indications for botulinum toxin in laryngectomy].
    Klap P; Marion MH; Perrin A; Fresnel-Elbaz E; Cohen M
    Rev Laryngol Otol Rhinol (Bord); 1993; 114(4):281-7. PubMed ID: 8029549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal effects of botulinum toxin injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia.
    Hogikyan ND; Wodchis WP; Spak C; Kileny PR
    J Voice; 2001 Dec; 15(4):576-86. PubMed ID: 11792036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of spasmodic dysphonia with botulinum toxin].
    Klap P; Marion MH; Perrin A; Fresnel-Elbaz E
    Ann Otolaryngol Chir Cervicofac; 1991; 108(8):477-82; discussion 482-3. PubMed ID: 1789624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin injection for treatment of spasmodic dysphonia: experience at Srinagarind Hospital.
    Srirompotong S; Saeseow P; Taweesaengsuksakul R; Kharmwan S; Srirompotong S
    J Med Assoc Thai; 2006 Dec; 89(12):2077-80. PubMed ID: 17214059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The swallowing side effects of botulinum toxin type A injection in spasmodic dysphonia.
    Buchholz DW; Neumann S
    Dysphagia; 1997; 12(1):59-60. PubMed ID: 8997837
    [No Abstract]   [Full Text] [Related]  

  • 9. Longitudinal effects of Botox injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia: part II.
    Rubin AD; Wodchis WP; Spak C; Kileny PR; Hogikyan ND
    Arch Otolaryngol Head Neck Surg; 2004 Apr; 130(4):415-20. PubMed ID: 15096423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin injection of the vocal fold for spasmodic dysphonia. A preliminary report.
    Miller RH; Woodson GE; Jankovic J
    Arch Otolaryngol Head Neck Surg; 1987 Jun; 113(6):603-5. PubMed ID: 3566940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unilateral versus bilateral botulinum toxin injections in spasmodic dysphonia: acoustic and perceptual results.
    Adams SG; Hunt EJ; Charles DA; Lang AE
    J Otolaryngol; 1993 Jun; 22(3):171-5. PubMed ID: 8371328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Singer's dystonia: first report of a variant of spasmodic dysphonia.
    Chitkara A; Meyer T; Keidar A; Blitzer A
    Ann Otol Rhinol Laryngol; 2006 Feb; 115(2):89-92. PubMed ID: 16514788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapeutic difficulties in spasmodic dysphonia--case report].
    Szkiełkowska A; Miaśkiewicz B; Baczyńska-Swierczyńska S; Szymańska E
    Pol Merkur Lekarski; 2006 May; 20(119):557-9. PubMed ID: 16875162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward improved differential diagnosis of adductor spasmodic dysphonia and muscle tension dysphonia.
    Roy N; Mauszycki SC; Merrill RM; Gouse M; Smith ME
    Folia Phoniatr Logop; 2007; 59(2):83-90. PubMed ID: 17337898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia.
    Troung DD; Rontal M; Rolnick M; Aronson AE; Mistura K
    Laryngoscope; 1991 Jun; 101(6 Pt 1):630-4. PubMed ID: 2041443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Historical approaches to the treatment of Adductor-Type Spasmodic Dysphonia (ADSD): review and tutorial.
    Pearson EJ; Sapienza CM
    NeuroRehabilitation; 2003; 18(4):325-38. PubMed ID: 14757929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceptual analyses of spasmodic dysphonia before and after treatment.
    Cannito MP; Woodson GE; Murry T; Bender B
    Arch Otolaryngol Head Neck Surg; 2004 Dec; 130(12):1393-9. PubMed ID: 15611398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonpharmacologic effects of botulinum toxin on the life quality of patients with spasmodic dysphonia.
    Anari S; Carding PN; Hawthorne MR; Deakin J; Drinnan MJ
    Laryngoscope; 2007 Oct; 117(10):1888-92. PubMed ID: 17690610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Listening: the key to diagnosing spasmodic dysphonia.
    Braden MN; Hapner ER
    ORL Head Neck Nurs; 2008; 26(1):8-12. PubMed ID: 18274236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Botulinum toxin therapy for abductor spasmodic dysphonia.
    Woodson G; Hochstetler H; Murry T
    J Voice; 2006 Mar; 20(1):137-43. PubMed ID: 16126369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.